Are you a health or performance professional thinking about a career change? Are you passionate about how technology can help progress your profession? If you have experience working in a clinical or high-performance setting and are
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)